NEXTSTELLIS
NEXTSTELLIS
Approved
DIN Number
02513218
Drug Class
Human
Market Date
Jun 15, 2021
Company
HC
searchlight pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02513218
AIG Number0262789001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AA18 DROSPIRENONE AND ESTETROL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
DROSPIRENONEActive
Strength: 3 MG
Monograph: DROSPIRENONE
ESTETROL MONOHYDRATEActive
Strength: 15 MG
Monograph: ESTETROL MONOHYDRATE